{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:11:16Z","timestamp":1775315476226,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the deposition of abnormal amyloid protein produced by a pathological plasma cell clone in various organs and soft tissues. Hematopoietic stem cell transplantation (HSCT) is an effective way to treat AL amyloidosis. Psoriasis is a common autoimmune disease (AID) and HSCT is a potential treatment for severe AIDs. We report a rare case of AL amyloidosis coincidence with psoriasis obtained continuous complete remission of the 2 diseases by autologous hematopoietic stem cell transplantation (ASCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 58-year-old man with a 30-year history of psoriasis complaining of edema and hypotension for 2 weeks was referred to our institution. His urine protein was quantified 2.83\u200ag\/day, without hematuria and decrease of glomerular filtration rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>Renal biopsy confirmed AL amyloidosis and multiple myeloma was excluded by bone marrow cytomorphologic examination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Chemotherapy regimen based on bortezomib and thalidomide had achieved hematologic partial remission, but the kidney had no response and psoriasis was still active. Furthermore, he received a standard myeloablative conditioning with high dose melphalan followed by ASCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The erythema with slivery scales of psoriasis vulgaris gradually improved and almost disappeared after granulocyte implantation. He obtained persistent hematological complete remission, organ response and recovery of psoriasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>We report a rare case of AL amyloidosis coincidence with psoriasis treated by ASCT. The outcome of this patient indicated that ASCT has therapeutic values both in AL amyloidosis and AIDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000013589","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T21:51:23Z","timestamp":1544824283000},"page":"e13589","source":"Crossref","is-referenced-by-count":11,"title":["Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation"],"prefix":"10.1097","volume":"97","author":[{"given":"Wencui","family":"Chen","sequence":"first","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Jinling Clinical Medical College of Nanjing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guisheng","family":"Ren","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zuo","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghua","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM200311063491920","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Sungur","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3324\/haematol.2009.008912","article-title":"Current treatment of AL amyloidosis","volume":"94","author":"Palladini","year":"2009","journal-title":"Haematologica"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"w13922","DOI":"10.4414\/smw.2014.13922","article-title":"A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation","volume":"144","author":"Raschle","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","article-title":"Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation","volume":"103","author":"Palladini","year":"2004","journal-title":"Blood"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"Nickoloff","year":"2004","journal-title":"J Clin Invest"},{"issue":"(Suppl 1)","key":"R6-20230914","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03165239","article-title":"Bone marrow transplantation for non-malignant disease","volume":"76","author":"Sullivan","year":"2002","journal-title":"Int J Hematol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","article-title":"How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/asheducation-2010.1.287","article-title":"Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy","volume":"2010","author":"Cohen","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000045450","article-title":"Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment. Case report and review of the literature","volume":"82","author":"Kagan","year":"1999","journal-title":"Nephron"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options","volume":"29","author":"Merlini","year":"2011","journal-title":"J Clin Oncol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3949\/ccjm.79a.11133","article-title":"Psoriasis: evolving treatment for a complex disease","volume":"79","author":"Villasenor-Park","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"Hugle","year":"2010","journal-title":"Haematologica"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri3226","article-title":"Emerging concepts in haematopoietic cell transplantation","volume":"12","author":"Li","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/14712598.2011.580272","article-title":"Autologous haemopoietic stem cell transplantation for autoimmune diseases","volume":"11","author":"Zeher","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/art.1780400923","article-title":"Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy","volume":"40","author":"Cooley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000089032","article-title":"Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation","volume":"212","author":"Masszi","year":"2006","journal-title":"Dermatology"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1200\/JCO.2008.17.6560","article-title":"Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma","volume":"26","author":"Braiteh","year":"2008","journal-title":"J Clin Oncol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/bmt.2012.68","article-title":"Complete resolution of guttate psoriasis following autologous SCT for Ewing's sarcoma in a pediatric patient","volume":"47","author":"Held","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R21-20230914","first-page":"E7","article-title":"Remission of psoriasis 13 years after autologous stem cell transplant","volume":"95","author":"Sung","year":"2015","journal-title":"Cutis"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1684\/ejd.2016.2893","article-title":"Remission of psoriasis after autologous stem cell transplantation\u2014until when?","volume":"27","author":"Azevedo","year":"2017","journal-title":"Eur J Dermatol"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2012.08.021","article-title":"Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation","volume":"68","author":"Kaffenberger","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812140-00066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:17:38Z","timestamp":1775312258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812140-00066"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013589","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}